Siemens Healthineers reported strong financial performance in its third quarter of fiscal year 2025, with a revenue increase of 7.6% over the same period last year.
For the period (end-June 30), the company posted revenues of 5.662 billion euros ($6.46 billion U.S.), up from 5.423 billion euros in the second quarter of 2024, and a net income of 556 million euros ($634.2 million), an 18% increase year over year.
The company cited its Imaging and Varian segments in particular for the revenue development. The company’s Imaging segment revenue grew to 3.24 billion euros ($3.7 billion), up 11.7% from 2.98 billion euros in the same period last year, while its Varian segment revenue increased by 8.7% to 978 million euros ($1.12 billion), up from 927 million euros ($1 billion) in the same period last year.
Meanwhile, the company’s Diagnostics segment experienced a slight revenue decline of 0.6% to 1.059 billion euros ($1.21 billion) compared with 1.107 billion euros ($1.263 billion) in the same period last year.
Across various geographical regions, revenue growth was significant for the company, particularly in the Americas and Asia Pacific. The Americas region saw a revenue increase of 12%, contributing 2.542 billion euros ($2.9 billion U.S.), while the Asia Pacific Japan region experienced a 9% growth, with revenues of 684 million euros ($780.2 million U.S.), the company posted.
Based on the results, Siemens Healthineers also revised its outlook for fiscal year 2025.
“We now expect comparable revenue growth of between 5.5% and 6% over fiscal year 2024 (previously between 5% and 6%) and adjusted basic earnings per share of between 2.30 euros and 2.45 euros (previously between 2.20 euros and 2.50 euros),” the company said.
